Newbury Pharmaceuticals ABNEWBRY 
$0.290.00%24h
0.00%24h
Global rank34246
Market cap$5.66M
Change 7d-
YTD Performance-5.73%
SP500 benchmarkUnderperform
P/E-0.29
P/S5.63
Revenue$1.01M
Earnings-$1.90M
Dividend yield-
Main Sector
Healthcare
EPS for Newbury Pharmaceuticals AB (NEWBRY)
Newbury Pharmaceuticals AB has an EPS of $-0.995382. In 2022, the company made an earnings per share (EPS) of $-0.751339. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for NEWBRY
-
Value:-
EPS history for Newbury Pharmaceuticals AB from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.995382 | 32.48% |
| 2022 | -$0.751339 | 111.93% |
| 2021 | -$0.354514 | - |
View the highest EPS stocks
